Parkinson's Disease Diagnosis via Joint Learning From Multiple Modalities and Relations.
DOI: 10.1109/jbhi.2018.2868420PMID: 30183649
The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson's Disease.
DOI: 10.1155/2018/9163040PMID: 30245802
Clinical Review Report: Levodopa/Carbidopa (Duodopa): (Abbvie Corporation): Indication: For the treatment of patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products, and, for whom the benefits of this treatment may outweigh the risks associated with the insertion and long-term use of the percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube required for administration
PMID: 30958666
Pharmacoeconomic Review Report: Levodopa/Carbidopa (Duodopa): (Abbvie Corporation): Indication: For the treatment of patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products, and, for whom the benefits of this treatment may outweigh the risks associated with the insertion and long-term use of the percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube required for administration
PMID: 30942993
The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
DOI: 10.1097/mjt.0000000000000623PMID: 28731860
Correction to: Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.
DOI: 10.1007/s00702-018-1884-2PMID: 29644396
Can telerehabilitation games lead to functional improvement of upper extremities in individuals with Parkinson's disease?
DOI: 10.1097/mrr.0000000000000291PMID: 29757774
Association Between Diabetic Retinopathy and Parkinson Disease: The Korean National Health Insurance Service Database.
DOI: 10.1210/jc.2017-02774PMID: 29982669
Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
DOI: 10.1097/wnr.0000000000001075PMID: 29985188
Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review.
DOI: 10.1097/wnf.0000000000000296PMID: 30004964
Efficacy of Parenteral Amantadine Therapy in the Treatment of Multiple System Atrophy With Predominant Parkinsonism.
DOI: 10.1097/wnf.0000000000000291PMID: 30024441
1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
DOI: 10.1016/j.jns.2018.07.011PMID: 30031172
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.
NeuralCipher